From signatures to models: understanding cancer using microarrays
- PMID: 15920529
- DOI: 10.1038/ng1561
From signatures to models: understanding cancer using microarrays
Abstract
Genomics has the potential to revolutionize the diagnosis and management of cancer by offering an unprecedented comprehensive view of the molecular underpinnings of pathology. Computational analysis is essential to transform the masses of generated data into a mechanistic understanding of disease. Here we review current research aimed at uncovering the modular organization and function of transcriptional networks and responses in cancer. We first describe how methods that analyze biological processes in terms of higher-level modules can identify robust signatures of disease mechanisms. We then discuss methods that aim to identify the regulatory mechanisms underlying these modules and processes. Finally, we show how comparative analysis, combining human data with model organisms, can lead to more robust findings. We conclude by discussing the challenges of generalizing these methods from cells to tissues and the opportunities they offer to improve cancer diagnosis and management.
Similar articles
-
Integrative analysis of the cancer transcriptome.Nat Genet. 2005 Jun;37 Suppl:S31-7. doi: 10.1038/ng1570. Nat Genet. 2005. PMID: 15920528 Review.
-
Expression genomics in breast cancer research: microarrays at the crossroads of biology and medicine.Breast Cancer Res. 2007;9(2):206. doi: 10.1186/bcr1662. Breast Cancer Res. 2007. PMID: 17397520 Free PMC article. Review.
-
Exploring genetic regulatory networks in metazoan development: methods and models.Physiol Genomics. 2002 Sep 3;10(3):131-43. doi: 10.1152/physiolgenomics.00072.2002. Physiol Genomics. 2002. PMID: 12209016 Review.
-
Genome-wide prediction of transcriptional regulatory elements of human promoters using gene expression and promoter analysis data.BMC Bioinformatics. 2006 Jul 4;7:330. doi: 10.1186/1471-2105-7-330. BMC Bioinformatics. 2006. PMID: 16817975 Free PMC article.
-
Where are we in genomics?J Physiol Pharmacol. 2005 Jun;56 Suppl 3:37-70. J Physiol Pharmacol. 2005. PMID: 16077195 Review.
Cited by
-
Gene selection and classification for cancer microarray data based on machine learning and similarity measures.BMC Genomics. 2011 Dec 23;12 Suppl 5(Suppl 5):S1. doi: 10.1186/1471-2164-12-S5-S1. Epub 2011 Dec 23. BMC Genomics. 2011. PMID: 22369383 Free PMC article.
-
Uniform, optimal signal processing of mapped deep-sequencing data.Nat Biotechnol. 2013 Jul;31(7):615-22. doi: 10.1038/nbt.2596. Epub 2013 Jun 16. Nat Biotechnol. 2013. PMID: 23770639
-
Prostate apoptosis response protein 4 sensitizes human colon cancer cells to chemotherapeutic 5-FU through mediation of an NF kappaB and microRNA network.Mol Cancer. 2010 Apr 30;9:98. doi: 10.1186/1476-4598-9-98. Mol Cancer. 2010. PMID: 20433755 Free PMC article.
-
Motif module map reveals enforcement of aging by continual NF-kappaB activity.Genes Dev. 2007 Dec 15;21(24):3244-57. doi: 10.1101/gad.1588507. Epub 2007 Nov 30. Genes Dev. 2007. PMID: 18055696 Free PMC article.
-
Transcriptional networks inferred from molecular signatures of breast cancer.Am J Pathol. 2008 Feb;172(2):495-509. doi: 10.2353/ajpath.2008.061079. Epub 2008 Jan 10. Am J Pathol. 2008. PMID: 18187569 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources